Patents by Inventor Joerg Buescher

Joerg Buescher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200308616
    Abstract: A method of producing steviol glycoside compositions and the use thereof in foods, beverages and other consumables, is described.
    Type: Application
    Filed: November 29, 2016
    Publication date: October 1, 2020
    Inventors: Avetik MARKOSYAN, Joerg BUESCHER, Guido MEURER, Petra ZUREK
  • Publication number: 20180265903
    Abstract: The present invention relates to the microbial production of malate. Fungal cells belonging to a species of the family of Ustilaginaceae were found to be an excellent host for the production of malate from glycerol. The malate production rate of fungal cells belonging to a species of the family of Ustilaginaceae was increased significantly by laboratory evolution. After medium optimization, a cultivation with the evolved strain on minimal medium with glycerol, or mono- or disaccharides, like glucose or sucrose or oligosaccharides yields a high production rate of malate.
    Type: Application
    Filed: December 21, 2015
    Publication date: September 20, 2018
    Inventors: Lars M. Blank, Nick Wierckx, Thiemo Zambanini, Eda Sarikaya, Joerg Buescher, Guido Meurer
  • Publication number: 20180016543
    Abstract: A method of producing yeast mutants and the use thereof. In order to provide yeasts which, at a given sugar content, produce a low ethanol content and a relatively high glycerol content in ethanolic fermentation and which are simultaneously obtainable rapidly, at least one yeast strain is contacted in a first mutagenesis step with a first mutagen and in a second mutagenesis step with a second mutagen. The first and second mutagens are different from one another and are selected from the following groups: nucleotide-alkylating agent, nucleotide-deaminating agent, and UV radiation. The method further includes a first selection step executed between the first and second mutagenesis steps and a second selection step being executed after the second mutagenesis step, in which the mutants that originate from the prior mutagenesis step in each case are exposed to a selection factor selected from the following groups: (a) hypertonic medium and (b) alcohol dehydrogenase inhibitor.
    Type: Application
    Filed: February 4, 2016
    Publication date: January 18, 2018
    Applicants: Erbslöh Geisenheim AG, BRAIN AG
    Inventors: Jürgen FRÖHLICH, Jürgen ECK, Guido MEURER, Christian NAUMER, Jörg BÜSCHER, Jörg MAMPEL